Scientists have uncovered a mechanism by which tumors exploit natural antioxidants to disable the immune cells tasked with destroying cancer, according to research that could reshape approaches to immunotherapy. The findings reveal that cancer cells release these antioxidants to shut down the body's defensive immune response, exploiting what researchers describe as a surprising vulnerability in human biology. The discovery offers a new explanation for why some tumors resist immune attack and may help account for the limited effectiveness of certain existing treatments.
In experiments conducted on mice, blocking this antioxidant-driven mechanism restored immune cell activity and improved responses to immunotherapy, suggesting a potentially promising pathway toward more effective cancer treatments. The research remains at the preclinical stage, and further studies will be required to determine whether the same mechanism operates in human patients and whether it can be safely targeted without disrupting normal immune function. The findings add to a growing body of work examining how tumors manipulate their surrounding environment to evade detection, and researchers say the results warrant continued investigation into combination therapies that pair immune checkpoint inhibitors with agents designed to interrupt this newly identified defense strategy.
Independent reporting synthesized from primary wires and global correspondents.